Pentoxifylline protects the small intestine after severe ischemia and reperfusion

Experimental and Clinical Transplantation

Volumn 11, Issue 3, 2013, Pages 250-258

  Carsi, José Miguel Lloris ^a,b   Lapeña, Dolores Cejalvo ^a   Toledo, Alexander Horacio ^c   Fernandez, Cristobal Zaragoza ^a   Pereyra, Luis Horacio Toledo ^d  

^a UNIVERSIDAD CATÓLICA DE VALENCIA SAN VICENTE MÁRTIR   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d WESTERN MICHIGAN UNIVERSITY HOMER STRYKER MD SCHOOL OF MEDICINE   (United States)

Author keywords

Ischemia and reperfusion; Pentoxifylline; Small intestine

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; LACTATE DEHYDROGENASE; LYSOZYME; MALONALDEHYDE; MYELOPEROXIDASE; PENTOXIFYLLINE; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DAMAGE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MECHANISM; HISTOPATHOLOGY; INTESTINE BLOOD FLOW; INTESTINE BRUSH BORDER; INTESTINE ISCHEMIA; INTESTINE NECROSIS; LABORATORY TEST; LACTATE DEHYDROGENASE BLOOD LEVEL; LASER DOPPLER FLOWMETRY; LIPID PEROXIDATION; MALE; MOLECULAR BIOLOGY; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PANETH CELL; PROTECTION; PROTEIN BLOOD LEVEL; RAT; REPERFUSION; SMALL INTESTINE DISEASE; SUPERIOR MESENTERIC ARTERY OBSTRUCTION; SURVIVAL RATE; TISSUE LEVEL;

ANIMALS; BIOLOGICAL MARKERS; BLOOD FLOW VELOCITY; CYTOPROTECTION; DISEASE MODELS, ANIMAL; INFLAMMATION MEDIATORS; INTERLEUKIN-1BETA; INTERLEUKIN-6; INTESTINE, SMALL; L-LACTATE DEHYDROGENASE; LASER-DOPPLER FLOWMETRY; MALE; MALONDIALDEHYDE; MESENTERIC VASCULAR OCCLUSION; NEUTROPHIL INFILTRATION; PENTOXIFYLLINE; PEROXIDASE; PROTECTIVE AGENTS; RATS; RATS, WISTAR; REPERFUSION INJURY; SPLANCHNIC CIRCULATION; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84880048492     PISSN: 13040855     EISSN: None     Source Type: Journal    
DOI: 10.6002/ect.2012.0222     Document Type: Article

References (47)

1. Gerstle JT, Bech FR, Walsh DB, Cronenwett JL. The effect of glucose infusion on survival after acute mesenteric ischemia/reperfusion. J Invest Surg. 1990;3(1):33-37.
2. Medeiros AC, Chacon DA, Sales VS, et al. Glucan and glutamine reduce bacterial translocation in rats subjected to intestinal ischemia-reperfusion. J Invest Surg. 2006;19(1):39-46.
3. Gutierrez Vega R, Toledo-Pereyra LH. Acute mesenteric small bowel ischemia in the rat. I. Protective effect of naloxone. Transplantation. 1990;49(4):830-833.
4. Tireli GA, Salman T, Ozbey H, Abbasoglu L, Toker G, Celik A. The effect of pentoxifylline on intestinal anastomotic healing after ischemia. Pediatr Surg Int. 2003;19(1-2):88-90.
5. Cavriani G, Domingos HV, Oliveira-Filho RM, Sudo-Hayashi LS, Vargaftig BB, de Lima WT. Lymphatic thoracic duct ligation modulates the serum levels of IL-1beta and IL-10 after intestinal ischemia/reperfusion in rats with the involvement of tumor necrosis factor alpha and nitric oxide. Shock. 2007;27(2):209-213.
6. Cámara-Lemarroy CR, Guzmán-de la Garza FJ, Alarcón-Galván G, Cordero-Pérez P, Muñoz-Espinosa LE, Fernández-Garza NE. Effects of thalidomide and pentoxyphylline over local and remote organ injury after intestinal ischemia/reperfusion. Transplant Proc. 2010;42(5):1624-1626.
7. Finkelstein I, Toledo-Pereyra LH, Castillo M, Castellanos J. Comparative analysis of pharmacological agents following small bowel ischemia. Transplant Proc. 1988;20(5):1043-1044.
8. Nesek-Adam V, Vnuk D, Rasić Z, Rumenjak V, Kos J, Krstonijević Z. Comparison of the effects of low intra-abdominal pressure and pentoxifylline on oxidative stress during CO2 pneumoperitoneum in rabbits. Eur Surg Res. 2009;43(4):330-337.
9. Rüdiger HA, Clavien PA. Tumor necrosis factor alpha, but not Fas, mediates hepatocellular apoptosis in the murine ischemic liver. Gastroenterology. 2002;122(1):202-210.
10. Demir T, Ulas F, Ozercan I, Ilhan N, Celiker U, Yasar MA. Protective effects of pentoxifylline in retinal ischemia/reperfusion injury. Ophthalmologica. 2003;217(5):337-341.
11. Zhang M, Xu YJ, Saini HK, Turan B, Liu PP, Dhalla NS. Pentoxifylline attenuates cardiac dysfunction and reduces TNF-alpha level in ischemic-reperfused heart. Am J Physiol Heart Circ Physiol. 2005;289(2):H832-H839.
12. El-Ghoneimi A, Cursio R, Schmid-Alliana A, et al. Inhibition of tumor necrosis factor alpha gene transcription by pentoxifylline reduces normothermic liver ischemia-reperfusion injury in rats. Transplant Proc. 2007;39(6):1761-1764.
13. Aslan A, Karagüzel G, Celik M, Uysal N, Yücel G, Melikoglu M. Pentoxifylline contributes to the hepatic cytoprotective process in rats undergoing hepatic ischemia and reperfusion injury. Eur Surg Res. 2001;33(4):285-290.
14. Mallick IH, Yang W, Winslet MC, Seifalian AM. Ischemia-reperfusion injury of the intestine and protective strategies against injury. Dig Dis Sci. 2004;49(9):1359-1377.
15. Yamamoto S, Tanabe M, Wakabayashi G, Shimazu M, Matsumoto K, Kitajima M. The role of tumor necrosis factor-alpha and interleukin-1beta in ischemia-reperfusion injury of the rat small intestine. J Surg Res. 2001;99(1):134-141.
16. Chen JC, Chen HM, Shyr MH, et al. Selective inhibition of inducible nitric oxide in ischemia-reperfusion of rat small intestine. J Formos Med Assoc. 2000;99(3):213-218.
17. Rosero O, Onody P, Stangl R, et al. Investigation of postconditioning in intestinal ischemia-reperfusion experimental models [in Hungarian]. Magy Seb. 2011;64(1):28-36.
18. Buemi A, Peters C, Laedlein-Greilsammer D. Use in histological technic of naphtol AS-D chloroacetate for demonstration of granulocyte series elements [in French]. Ann Anat Pathol (Paris). 1978;23(3):241-247.
19. Oksuz H, Bulbuloglu E, Senoglu N, et al. Re-protective effects of pre-and post-laparoscopy conditioning, zinc, pentoxifylline, and Nacetylcysteine in an animal model of laparoscopy-induced ischemia/reperfusion injury of the kidney. Ren Fail. 2009;31(4):297-302.
20. El-Ghoneimi A, Cursio R, Schmid-Alliana A, et al. Pentoxifylline inhibits liver expression of tumor necrosis factor alpha mRNA following normothermic ischemia-reperfusion. HPB (Oxford). 2007;9(2):112-119.
21. Ji Q, Zhang L, Lv R, Jia H, Xu J. Pentoxifylline decreases up-regulated nuclear factor kappa B activation and cytokine production in the rat retina following transient ischemia. Ophthalmologica. 2006;220(4):217-224.
22. Wiernsperger N, Rapin JR. Microvascular diseases: is a new era coming? Cardiovasc Hematol Agents Med Chem. 2012;10(2):167-183.
23. Liu Y, Shakur Y, Kambayashi J. Phosphodiesterases as targets for intermittent claudication. In: Francis SH, Conti M, Miles D, eds. Phosphodiesterases as Drug Targets (Handbook of Experimental Pharmacology). New York, NY, Springer Healthcare LLC; 2011: 211-236.
24. Waxman K, Holness R, Tominaga G, Oslund S, Pinderski L, Soliman MH. Pentoxifylline improves tissue oxygenation after hemorrhagic shock. Surgery. 1987;102(2):358-361.
25. Coccia MT, Waxman K, Soliman MH, Tominaga G, Pinderski L. Pentoxifylline improves survival following hemorrhagic shock. Crit Care Med. 1989;17(1):36-38.
26. Flynn WJ, Cryer HG, Garrison RN. Pentoxifylline restores intestinal microvascular blood flow during resuscitated hemorrhagic shock. Surgery. 1991;110(2):350-356.
27. Sakio H, Tanaka Y, Ueno K, Oishi S, Ohtsu S, Okuda C. How should we treat intestinal ischemia?--II: Effects of pentoxifylline, glucagons and prostaglandin E1 [in Japanese]. Masui. 1995;44(2):227-232.
28. Mustafa NA, Yandi M, Albayrak L, Yildiz K. Effect of pentoxifylline on the ischemia-reperfusion injury of the intestine. Int Surg. 1995;80(2):152-155.
29. Udassin R, Vromen A, Seror D, Haskel Y. Pentoxifylline attenuates ischemia/reperfusion injury to the small intestine in the rat. Pediatr Surg Int. 1996;11(5-6):329-333.
30. Savaş C, Aras T, Cakmak M, et al. Pentoxifylline inhibits overflow and reduces intestinal reperfusion injury. J Pediatr Surg. 1997;32(6):905-910.
31. Hammerman C, Goldschmidt D, Caplan MS, et al. Amelioration of ischemia-reperfusion injury in rat intestine by pentoxifyllinemediated inhibition of xanthine oxidase. J Pediatr Gastroenterol Nutr. 1999;29(1):69-74.
32. Sener G, Akgün U, Satiroǧlu H, Topaloǧlu U, Keyer-Uysal M. The effect of pentoxifylline on intestinal ischemia/reperfusion injury. Fundam Clin Pharmacol. 2001;15(1):19-22.
33. Sullivan GW, Carper HT, Novick WJ Jr, Mandell GL. Inhibition of the inflammatory action of interleukin-1 and tumor necrosis factor (alpha) on neutrophil function by pentoxifylline. Infect Immun. 1988;56(7):1722-1729.
34. Bieri JG, Anderson AA. Peroxidation of lipids in tissue homogenates as related to vitamin E. Arch Biochem Biophys. 1960;90(1):105-110.
35. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979;95(2):351-358.
36. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193(1):265-275.
37. Renlund DG. A quantitative and sensitive method for measurement of myeloperoxidase. Clin Res. 1980;28:75-81.
38. Suzuki K, Ota H, Sasagawa S, Sakatani T, Fujikura T. Assay method for myeloperoxidase in human polymorphonuclear leukocytes. Anal Biochem. 1983;132(2):345-352.
39. Dernfalk J, Persson Waller K, Johannisson A. The xMAP technique can be used for detection of the inflammatory cytokines IL-1beta, IL-6 and TNF-alpha in bovine samples. Vet Immunol Immunopathol. 2007;118(1-2):40-49.
40. Feld AD, Fondacaro JD, Holloway GA Jr, Jacobson ED. Measurement of mucosal blood flow in the canine intestine with laser doppler velocimetry. Life Sci. 1982;31(14):1509-1517.
41. Durlik M, Benichoux R, Lopez-Gollonet JM, Karcher G. A new laser Doppler interface for the continuous measurement of the rat gastric mucosal blood flow. Eur Surg Res. 1986;18(1):41-49.
42. Mörsky P. Detection of lysozyme and alpha 2-macroglobulin--lysozyme complexes by immunoblotting. Clin Chim Acta. 1988;178(3):327-336.
43. Pinkus GS, Pinkus JL. Myeloperoxidase: a specific marker for myeloid cells in paraffin sections. Mod Pathol. 1991;4(6):733-741.
44. Perry BC, Soltys D, Toledo AH, Toledo-Pereyra LH. Tumor necrosis factor-α in liver ischemia/reperfusion injury. J Invest Surg. 2011;24(4):178-188.
45. Walsh KB, Toledo AH, Rivera-Chavez FA, Lopez-Neblina F, Toledo-Pereyra LH. Inflammatory mediators of liver ischemia-reperfusion injury. Exp Clin Transplant. 2009;7(2):78-93.
46. Phillips L, Toledo AH, Lopez-Neblina F, Anaya-Prado R, Toledo-Pereyra LH. Nitric oxide mechanism of protection in ischemia and reperfusion injury. J Invest Surg. 2009;22(1):46-55.
47. Suzuki S. Cellular and Molecular Biology of Ischemia Reperfusion. In: Toledo-Pereyra LH, ed. Organ Preservation for Transplantation (Medical Intelligence Unit). Austin, Texas: Landes Bioscience; 2010:58-90.